A blood-based metabolomic signature predictive of risk for pancreatic cancer

Irajizad, E., Kenney, A., Tang, T., Vykoukal, J., Wu, R., Murage, E., Dennison, J. B., Sans, M., Long, J. P., Loftus, M., Chabot, J. A., Kluger, M. D., Kastrinos, F., Brais, L., Babic, A., Jajoo, K., Lee, L. S., Clancy, T. E., Ng, K., … Fahrmann, J. F. (2023). A blood-based metabolomic signature predictive of risk for pancreatic cancer. Cell Reports Medicine, 4(9), 101194. https://doi.org/10.1016/j.xcrm.2023.101194
Authors:
Ehsan Irajizad
Ana Kenney
Tiffany M. Tang
Jody Vykoukal
Ranran Wu
Eunice Murage
Jennifer B. Dennison
Marta Sans
James P. Long
Maureen Loftus
John A. Chabot
Michael D. Kluger
Fay Kastrinos
Lauren K. Brais
Ana Babić
Kunal Jajoo
Linda Lee
Thomas E. Clancy
Kimmie Ng
Andrea J. Bullock
Jeanine M. Genkinger
Anirban Maitra
Kim‐Anh Do
Bin Yu
Brian M. Wolpin
Samir Hanash
Johannes F. Fahrmann
Affiliated Authors:
John A. Chabot
Michael D. Kluger
Fay Kastrinos
Jeanine M. Genkinger
Columbia Affiliation:
Subjects:
CA-19-9 Antigen (MeSH)
Pancreatic Neoplasms (MeSH)
Pancreatic Cancer Research and Treatment (OpenAlex Topic)
Diversity and Function of Gut Microbiome (OpenAlex Topic)
Advances in Metabolomics Research (OpenAlex Topic)
Author Keywords:
biomarker
metabolites
microbiome
pancreatic cancer
risk assessment
elink
Publication Type:
Article
Unique ID:
10.1016/j.xcrm.2023.101194
PMID:
37729870
DOI:
10.1016/j.xcrm.2023.101194
Journal:
Cell Reports Medicine
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record

Record Created: